To assess the clinical efficacy and safety of denosumab in the prevention and treatment of osteoporosis compared to placebo or active comparator in postmenopausal women.
This is a protocol.
Denosumab for the treatment and prevention of postmenopausal osteoporosis
You may also be interested in:
- Pharmacologic interventions for preventing and treating periprosthetic osteoporosis following total hip arthroplasty
- Selective estrogen receptor modulators for preventing and treating postmenopausal osteoporosis
- Statins for osteoporosis in postmenopausal women
- Etidronate for preventing fractures caused by osteoporosis in postmenopausal women
- Intravenous zoledronate for postmenopausal osteoporosis
Health topics: